In these case-matched serial section primary CRC lesions, positive HLA-G expression was observed in 70.7% (268/379) with mAb 4H84 and in 60.4% (219/379) with mAb 5A6G7 in CRC patients. This evidence concerns the gene HLA-G and colorectal carcinoma.